CAS: 1078166-57-0 - 1-(4-Fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]-3-azetidinecarboxylic acid
- Sinónimos:
- Pf 04418948
- 1-(4-Fluorobenzoyl)-3-[(6-Methoxynaphthalen-2-Yl)Oxymethyl]Azetidine-3-Carboxylic Acid
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
PF 04418948 REF: IN-DA008TMWCAS: 1078166-57-0 | % | A consultar | Lun 02 Dic 24 | |
PF-04418948 REF: TM-T3306CAS: 1078166-57-0 | 97.61% - 99.45% | 47,00 €~348,00 € | Mar 10 Dic 24 | |
PF 04418948 REF: TR-P218295CAS: 1078166-57-0 | - - - | 1.056,00 € | Mar 14 Ene 25 | |
PF-04418948 REF: 3D-DTB16657CAS: 1078166-57-0 | Min. 95% | A consultar | Lun 13 Ene 25 |
Ref: IN-DA008TMW
5mg | 62,00 € | ||
10mg | 100,00 € | ||
25mg | 163,00 € | ||
50mg | 196,00 € | ||
100mg | 313,00 € | ||
250mg | 499,00 € |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
PF-04418948
CAS:1078166-57-0
PF-04418948 is a potent EP2 receptor antagonist. Displays over 2000-fold selectivity for EP2 receptors over …
Fórmula:
C23H20FNO5
Pureza:
97.61% - 99.45%
Forma y color:
Solid
Peso molecular:
409.41
Ref: TM-T3306
2mg | 47,00 € | ||
5mg | 68,00 € | ||
10mg | 87,00 € | ||
25mg | 183,00 € | ||
50mg | 315,00 € | ||
100mg | 348,00 € | ||
1mL*10mM (DMSO) | 75,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
PF 04418948
Producto controladoCAS:1078166-57-0
Applications PF 04418948 acts as a novel, potent and selective prostoglandin EP2 receptor antagonist. References …
Fórmula:
C23H20FNO5
Forma y color:
Neat
Peso molecular:
409.407
Ref: TR-P218295
50mg | 1.056,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
PF-04418948
CAS:1078166-57-0
PF-04418948 is a potent and selective antagonist of the camp receptor. It inhibits the binding …
Fórmula:
C23H20FNO5
Pureza:
Min. 95%
Peso molecular:
409.41 g/mol
Ref: 3D-DTB16657
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025